• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTAPRO; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTAPRO; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Lot Number RP001030
Device Problems Unstable (1667); Output Problem (3005)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2020
Event Type  malfunction  
Event Description
It was reported that speed increased during the procedure.A rotapro console was selected for an atherectomy procedure.The speed was set to 180,000 rotations per minute (rpm).Rotation speed during ablation at the lesion increased.There were no patient complications reported.
 
Event Description
It was reported that speed increased during the procedure.A rotapro console was selected for an atherectomy procedure.The speed was set to 180,000 rotations per minute (rpm).Rotation speed during ablation at the lesion increased.There were no patient complications reported.It was further reported that the target lesion was moderately calcified and located in mildly tortuous anatomy within the left anterior descending artery.The device exceeded the set speed with a maximum rotation speed of 190,000 rpm.The procedure was completed with this device.
 
Event Description
It was reported that speed increased during the procedure.A rotapro console was selected for an atherectomy procedure.The speed was set to 180,000 rotations per minute (rpm).Rotation speed during ablation at the lesion increased.There were no patient complications reported.It was further reported that the target lesion was moderately calcified and located in mildly tortuous anatomy within the left anterior descending artery.The device exceeded the set speed with a maximum rotation speed of 190,000 rpm.The procedure was completed with this device.
 
Manufacturer Narrative
Device eval by mfr: the console was returned in over all good physical condition.The console failed incoming functional testing.The console failed intermittently.It failed to activate turbine flow in normal mode when the knob button on the advancer simulator was pressed.Console also failed due to poor electrical contact between the male connector of the advance simulator and the female electrical connector on the console.This triggers the shutoff of the air supply to the console during testing.The air supply is shut down whenever the advancer simulator connector or cable is touched.This points to a defective electrical connector.However, the reported jumping in speed was not duplicated.The front housing assembly which contains the electrical connector was replaced.That resolved the intermittent issues.The rotapro passed calibration and full functional final testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTAPRO
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11012783
MDR Text Key221808547
Report Number2134265-2020-17822
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 04/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot NumberRP001030
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/15/2021
Initial Date Manufacturer Received 12/01/2020
Initial Date FDA Received12/15/2020
Supplement Dates Manufacturer Received12/22/2020
03/18/2021
Supplement Dates FDA Received01/07/2021
04/12/2021
Patient Sequence Number1
-
-